Medication info
Zimer Tablet 5 mg (Memantine Hydrochloride)

Zimer Tablet 5 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceuticals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202503192 · Approved 2025.12.08

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily and should be taken at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, reach the maintenance dose by increasing the dose by 5mg per week over the first 3 weeks as follows. First week (Day 1~Day 7): Administer 5mg once daily for 7 days. Second week (Day 8~Day 14): Administer 10mg once daily for 7 days. Third week (Day 15~Day 21): Administer 15mg once daily for 7 days. From the fourth week onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. Elderly Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg once daily. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Unimed Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This drug is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily and should be taken at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, reach the maintenance dose by increasing the dose by 5mg per week over the first 3 weeks as follows. First week (Day 1~Day 7): Administer 5mg once daily for 7 days. Second week (Day 8~Day 14): Administer 10mg once daily for 7 days. Third week (Day 15~Day 21): Administer 15mg once daily for 7 days. From the fourth week onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. Elderly Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg once daily. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients who are allergic to any of its components, those with severely impaired liver function, and those with severely reduced kidney function. Caution should be exercised when administering this drug to patients with epilepsy or those who have a history of seizures, as well as to individuals predisposed to epilepsy. Additionally, it is advisable not to use this drug in combination with NMDA receptor antagonists such as amantadine, ketamine, or dextromethorphan, as it may increase the risk of central nervous system side effects. Patients in conditions or situations where the acidity (pH) of urine may increase should be monitored closely. There is insufficient evidence regarding the safety of this drug in patients with heart disease or uncontrolled hypertension, thus caution is required. While taking this drug, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; if these symptoms appear, medical consultation should be sought. This drug may interact with other medications, particularly with levodopa, dopamine agonists, anticholinergic drugs, barbiturates, antipsychotic medications, and skeletal muscle relaxants, and caution is recommended in such cases. Pregnant women or women who may become pregnant should use this drug only if absolutely necessary, as there may be risks to the fetus. Breastfeeding mothers are advised to discontinue breastfeeding as this drug may be transferred into breast milk. This drug should not be used in children or adolescents under 18 years old as its safety and efficacy have not been established. In the event of an overdose, central nervous system symptoms such as confusion, drowsiness, dizziness, hallucinations, seizures, as well as gastrointestinal symptoms such as vomiting and diarrhea may occur, and immediate medical attention should be sought. This drug may slow down the response rate of patients, so caution is required while driving or operating machinery. Lastly, this drug must be kept out of reach of children and should not be transferred to other containers as this may affect its quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorder
  • gait abnormality
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • respiratory distress
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • non-specific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air or moisture from entering. The storage temperature should ideally be maintained between 1 and 30 degrees Celsius at room temperature to preserve its effectiveness over time.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.